Cardiovascular collapse and refractory bronchospasm following administration of vancomycin, esmolol, and heparin.
Bloom
B
B
Department of Cardiothoracic Anesthesia, Albany Medical Center, NY 12208.
Chalmers
P C
PC
Danker
P R
PR
Kumar
S
S
Sheikh
F
F
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000368:Aged; D000707:Anaphylaxis / Q000139:chemically induced; D000787:Angina Pectoris / Q000601:surgery; D001794:Blood Pressure / Q000187:drug effects; D001986:Bronchial Spasm / Q000139:chemically induced*; D002302:Cardiac Output / Q000187:drug effects; D004342:Drug Hypersensitivity / Q000209:etiology; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D011412:Propanolamines / Q000009:adverse effects*; D012131:Respiratory Insufficiency / Q000139:chemically induced; D012769:Shock / Q000139:chemically induced*; D014640:Vancomycin / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D014640:Vancomycin; D006493:Heparin; C036604:esmolol